DFTX SCHEDULE 13G: SEC filing
Janus Henderson Group Ltd.
Filed with the SEC on · accession 0001274173-26-000279
DFTX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. Janus Henderson Group Ltd. filed a Schedule 13G reporting beneficial ownership of 7,196,318 common shares, or 5.4%, of Definium Therapeutics, Inc. as of September 30, 2026. The stock moved -6.0% by the first close after the filing.
Summary of the filing
Janus Henderson Group Ltd. filed a Schedule 13G reporting beneficial ownership of 7,196,318 common shares, or 5.4%, of Definium Therapeutics, Inc. as of September 30, 2026. The filing is a passive institutional ownership disclosure.
Key details
How DFTX stock reacted
Close before
$32.08
Nov 13, 2026
First close after
-5.99%
$30.16
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DFTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DFTX?
Click hereFrequently asked questions
What did DFTX file with the SEC on Nov 16, 2026?
DFTX filed a SCHEDULE 13G (SEC filing). Janus Henderson Group Ltd. filed a Schedule 13G reporting beneficial ownership of 7,196,318 common shares, or 5.4%, of Definium Therapeutics, Inc. as of September 30, 2026. The filing is a passive institutional ownership disclosure.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did DFTX stock react to this filing?
DFTX closed at $32.08 before the filing and $30.16 on Nov 16, 2026 (-5.99%).
Other DFTX SEC filings
- SCHEDULE 13G · SEC filingNov 13, 2026
- 10-Q · SEC filingNov 9, 2026
- 8-K · SEC filingNov 9, 2026
- SCHEDULE 13G · SEC filingNov 5, 2026
- 8-K · SEC filingSep 14, 2026
- 8-K · Fda approvalSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 6, 2026
Get alerts when DFTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days